跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 51 条关于
“Gubra”
全部
51
临床试验
14
药物
23
机构
1
资讯
13
8个月前
Gubra Expands Facilities by 70% to Support Growing Peptide Drug Pipeline and CRO Operations
去年
AbbVie Enters Obesity Market with $350M Gubra Deal for Novel Amylin Analog
29天前
Gubra Advances Obesity Pipeline as AbbVie and Boehringer Ingelheim Programs Reach Phase 2
11个月前
PILA PHARMA Partners with Gubra for Preclinical Obesity Trials of TRPV1 Inhibitor XEN-D0501
8个月前
Amylyx Advances AMX0318 as Long-Acting GLP-1 Receptor Antagonist for Post-Bariatric Hypoglycemia
2年前
Breakthroughs and Trends in Anti-Obesity Drug Development for 2024
9个月前
Tangram Therapeutics Advances Novel RNAi Therapy TGM-312 to Clinical Trials for MASH Treatment
6个月前
Tangram Therapeutics Initiates First-in-Human Trial of TGM-312 for MASH Treatment
去年
Biotech Deal Landscape: February-March 2025 Sees Surge in Partnerships Across Multiple Therapeutic Areas
去年
MetaVia's DA-1241 Shows Enhanced Hepatoprotective Effects in MASH Combination Therapy
第 1 页,共 2 页
上一页
下一页